All-Medications.com | Bookmark Website | Bookmark Page |   Alerid   Alfacip   Amlopres   Ampisyn   Beclate   Budecort   Carloc   Cefasyn   Cefoprox   Cephadex   Ciplactin   Citadep   Clopivas   Cobix   Cromal   Cytomid   Cytotam   Danogen   Diaglip   Dilvas   Doxacard   Duolin   Duovir   Emeset   Etosid   Famtrex   Fertomid   Fincar   Flohale   Flomist   Forcan   Ginette   Glumet   Hipres   Ibugesic   Ipravent   Lomac   Mebex   Metolar   Misoprost   Modafinil   Montair   Norflox   Novamox   Osteofos   Oxyspas   Pantosec   Paracip   Pirox   Pletoz   Ralista   Ramipres   Serobid   Seroflo   Stavir   Terol   Tibofem   Tiova   Tramacip   Ulcimax   Venlor   Warf   Zidovir   Zoflut Buy Emeset now! Pharmacy Order       USA Pharmacy Buy Emeset       Emeset.    Tablets/Injections Structure. Emeset-4 Tablets = Ondansetron Hydrochloride Dihydrate equivalent to Ondansetron 4mg Emeset-8 Tablets = Ondansetron Hydrochloride Dihydrate equivalent to Ondansetron 8mg Emeset 2 ml Injection 2 ml ampoule = Ondansetron Hydrochloride Dihydrate Equivalent to Ondansetron 4mg and water for injection IP q.s. Emeset 4 ml Injection 4 ml ampoule = Ondansetron Hydrochloride Dihydrate Equivalent to Ondansetron 8mg and water for injection IP q.s.    Usage. Emeset is used for management of a nausea and vomitting caused cytotoxic chemotherapy and radiotheraphy, and for prevention and treatment post-operative nauseas and tearing (PONV).    Recommended dosage. Chemotherapy of a cancer and radiotheraphy Adults Highly Emetogenic Chemotherapy Day 1 Days 2 - 5 Unique dosage of 8 mg a slow intravenous injection immediately before chemotherapy of 8 mg orally twice daily for till 5 days or dosage of 8 mg slow intravenous Injection immediately before The chemotherapy, accompanied two further intravenous dosages of 8 mg two - four hours separately, or constant injection from 1 mg / hour for till 24 o'clock 8 mg orally twice daily for till 5 days or unique dosage of 32 mg dissolved in 50-100 ml of saline soil or another the compatible liquid of injection also installed within not less than 15 minutes immediately before chemotherapy of 8 mg orally twice daily for about five days Emetogenic Chemotherapy/Radiotherapy Day 1 Days 2 - 5 Unique dosage of controlled 8 mg as a slow intravenous injection immediately before chemotherapy / radiotheraphy of 8 mg orally twice daily for till 5 days or 8 mg orally, 1-2 hours vefore chemotherapy / the radiotheraphy followed on 8 mg orally 12 hourly 8 mg orally twice daily for till 5 days Children Emetogenic Chemotherapy/Radiotherapy Day 1 Days 2 - 5 Unique intravenous dosage 5mg/m2 immediately before chemotherapy accompanied on 4 mg orally 12 hours after 4 mg orally twice daily for till 5 days * In both, adult and children, in high emetogenic chemotherapy, efficiency ondansetron in the first 24 hours can be increased addition of a unique intravenous dosage phosphate of sodium of dexamethasone on 20 mg up to chemotherapy Elderly and in kidney function to which harm, any change of a dosage, frequency of a dosage or route of administration not required in patients more than 65 years or with kidney deterioration. In function hepatic to which harm, in patients with moderate or serious deterioration hepatic, a full daily dosage from 8 mg should not be exceeded. Post-operative Nausea and Vomiting (PONV) DOSAGE For prevention post-operative nauseas and tearing 8 mg, the data orally one hour before the anesthesia, 8 mg accompanied with two further dosages in eight-hourly intervals or unique dosage of pure 4 mg given by a slow intravenous injection in an induction of anesthesia for treatment established post-operative nauseas and vomittings a unique dosage of the pure{clean} 4 mg given by a slow intravenous injection Pediatric use There is no experience in use ondansetron in prevention and treatment post-operative nauseas and tearing in children. In elderly There experience in use ondansetron in prevention is limited both treatment post-operative nauseas and tearing in elderly. In kidney function to which harm, any change of a daily dosage or frequency of a somnolence, or route the administration is required. In function hepatic to which harm, carrying out of calculations ondansetron is considerably reduced and half-life wheys considerably long in subjects with moderate or serious deterioration function hepatic. In such patients the full daily dosage of 8 mg should not be exceeded. Compatibility with intravenous liquids According to good pharmaceutical practice, intravenous decisions should be it is ready during injection with the following recommended injection decisions: - Chloride of sodium intravenous IP injections of 0.9 % w/v - Dextrose intravenous IP injections of 5 % w/v - Mannitol intravenous IP injections of 10 % w/v - Intravenous decision of Ringers - Potassium chloride of 0.3 % w/v and glucose of 5 % w/v    Warnings and Precautions. Hypersensitivity to any component of drug. Medicines Online Information